Oscar will appeal its case against Florida Blue over the use of exclusive broker policies, which Oscar alleges is anticompetitive, company officials said Tuesday, October 15.
The startup health insurer announced it is filing an appeal because it “refuses to stand by as Florida Blue enforces this anti-consumer, anti-competitive policy.”
In September, a federal judge in Florida ruled against Oscar in siding with Florida Blue to dismiss the case. Exclusive broker policies are shielded from antitrust scrutiny under federal law, the judge ruled.
“Oscar is committed to consumer choice and refuses to stand by as Florida Blue enforces this anti-consumer, anti-competitive policy,” the company stated.
In an emailed statement, Florida Blue stated it will “continue to vigorously defend against this lawsuit on appeal, all the while continuing to support our contracted general agents who are striving to deliver on our mission of helping the people and communities of Florida achieve better health.”
Full Content: Modern Health Care
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
DOJ and FTC Introduce Website for Reporting Anti-Competitive Healthcare Practices
Apr 18, 2024 by
CPI
US Congress Advances Legislation to Compel TikTok Sale
Apr 18, 2024 by
CPI
UK Financial Sector Advocates Enhanced Regulatory Accountability
Apr 18, 2024 by
CPI
Google and All 50 States Defend $700 Million Consumer Settlement
Apr 18, 2024 by
CPI
Colorado Enacts First Law to Protect Consumer Brainwave Data
Apr 18, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – China Edition – Year of the Dragon
Apr 16, 2024 by
CPI
Review Logic and Rules for Concentrations of Undertakings that Do Not Meet the Standard of Notification
Apr 16, 2024 by
CPI
China’s Review of Semiconductor Transactions
Apr 16, 2024 by
CPI
Key Challenges and Tips for Merger Control Filing in China for Listed Companies
Apr 16, 2024 by
CPI
Key Point Review: China SPC Antitrust Judgments in 2023
Apr 16, 2024 by
CPI